Tagged: Equity Shares

Biocon’s Earnings Surge in Q1 FY16

IMS, TSA May MAT 2015). CANMAb™, our affordable biosimilar Trastuzumab continues to gain traction as a life-saving therapy for HER2-positive metastatic breast cancer patients. Novel Molecules A scientific paper titled ‘Long-term Efficacy and Safety...

More